Statements

CSRxP: U.S. SUPREME COURT DECISION HELPS SAFEGUARDS CRITICAL PATHWAY FOR GENERIC COMPETITION

Jun 4, 2026

Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. Ruling Will Help Protect Read More

CSRxP STATEMENT ON PRESIDENT TRUMP’S STATE OF THE UNION ADDRESS

Feb 24, 2026

Administration and Congress Must Enact Market-Based Solutions to Hold Big Read More

CSRxP Statement on the Launch of TrumpRx

Feb 6, 2026

Campaign Appreciates Administration’s Commitment to Lowering Drug Prices, Read More

CSRxP STATEMENT ON THE PASSING OF DAVID MITCHELL

Jan 5, 2026

Founder and President of Patients for Affordable Drugs Was a Tireless and Read More

CSRxP: BIG PHARMA RINGS IN 2026 WITH MORE THAN 300 PRICE INCREASES ON BRAND NAME DRUGS, OUTPACING START OF 2025

Jan 5, 2026

Big Pharma Giants Including Pfizer and GSK Kickoff a New Year with Price Hikes Read More